UHS Stock Analysis: Buy, Sell, or Hold?
UHS - Universal Health Services, Inc. Class B
$177.94
-1.03 (-0.58%)
▼
5d:
-4.7%
30d:
-13.14%
90d:
-20.94%
BUY
HIGH Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: Apr 27, 2026
24d
Smart Money Accumulation
UHS is down 3.9% this week, but smart money is accumulating calls. Top strike: $220 2026-05-15 with 1 OI. Call ratio: 100% View Scanner →
Strength: 6.9/10
Get Alerted When UHS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: UHS appears deeply undervalued. Market expects -7.6% annual earnings decline despite 43% recent earnings growth. Contrarian opportunity at discount to historical valuation.
✅ BUY SIGNAL: UHS appears deeply undervalued. Market expects -7.6% annual earnings decline despite 43% recent earnings growth. Contrarian opportunity at discount to historical valuation.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$308.16
Based on 6.5% avg growth
INTRINSIC VALUE TODAY
$191.34
7.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: UHS is currently trading at $177.94, which is considered oversold relative to its 30-day fair value range of $180.88 to $209.95. From a valuation perspective, the stock is trading at a discount (Forward PE: 7.0) compared to its historical average (8.8). Remarkably, the market is currently pricing in an annual earnings decline of 7.6% over the next few years. This pessimistic expectation contrasts with the company's recent 42.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, UHS is in a strong downtrend. The price is currently testing key support at $176.21. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $248.76 (+39.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, UHS is in a strong downtrend. The price is currently testing key support at $176.21. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $248.76 (+39.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$180.88 -
$209.95
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
83.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 39.8% below Wall St target ($248.76)
Fair Price Analysis
30-Day Fair Range
$180.88 -
$209.95
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$10.05
(5.6%)
Support & Resistance Levels
Support Level
$176.21
Resistance Level
$191.40
Current Trend
Strong Downtrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.96
Wall Street Target
$248.76
(+39.8%)
Revenue Growth (YoY)
9.1%
Earnings Growth (YoY)
42.7%
Profit Margin
8.6%
Valuation Discount vs History
-7.6% cheaper
PE vs Historical
7.0 vs 8.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.6%
(market-implied from PE analysis)
1-Year Target
$164.42
(-8%)
2-Year Target
$151.92
(-15%)
3-Year Target
$140.37
(-21%)
3-Yr Target (if PE normalizes)
(PE: 7→9)
$177.56
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 9.0%)
$741.00
(+316%)
Base:
(SPY PE: 7.0, Growth: 9.0%)
$230.66
(+30%)
Bear:
(PE: 5.9, Growth: 9.0%)
$196.06
(+10%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (8x PE), but valuation improves significantly next year (7x PE) as earnings recover.
Trailing PE: 8.04 | Current EPS (TTM): $23.10
Bull Case
$226.32
(+20%)
Analyst growth 10.7%, PE expands to 8.9
Base Case
$205.75
(+9%)
Market implied 10.7%, PE stable at 8.0
Bear Case
$126.36
(-33%)
Severe decline -20.0%, PE contracts to 6.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 7.0 to 8.8
Stabilization Target:
$225.08
(+26.5%)
PE Expansion Potential:
+26.5%
Share & Embed Analysis
Last updated: April 02, 2026 9:04 AM ET
Data refreshes hourly during market hours. Next update: 10:04 AM
Data refreshes hourly during market hours. Next update: 10:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is UHS showing a specific setup today?
Insider Activity (6 Months)
2
Buys
2
Sells
0
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
BUY
2026-02-24
Ro Khanna
BUY
2026-01-29
Warren J Nimetz
SELL
3817 shares
2025-11-11
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$261 | 58 HOLD |
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$543 | 58 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$143 | 53 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 47 HOLD |
|
ASTH
Astrana Health Inc |
STRONG BUY
12 analysts |
$36 | 65 BUY |
Advanced UHS Option Strategies
Professional options setups generated by AI based on today's UHS price and gamma walls.
